High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

Source: News Medical

Sep 16, 2022 | Research

As cannabidiol (CBD) use rises, high-quality randomized clinical trials are needed to determine if anti-inflammatory benefits of CBD for heart disease seen in preclinical data will work in a real-world setting, according to research presented at ACC Latin America 2022.  Read the article here.


Click here to learn how STEM selects new articles.